» Articles » PMID: 11280300

Single-lumen Subcutaneous Ports Inserted by Interventional Radiologists in Patients Undergoing Chemotherapy: Incidence of Infection and Outcome of Attempted Catheter Salvage

Overview
Journal Arch Intern Med
Specialty General Medicine
Date 2001 Mar 31
PMID 11280300
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Subcutaneous ports are commonly used for vascular access in patients with cancer undergoing chemotherapy.

Objectives: To determine the incidence of catheter-related infection and to assess the efficacy of catheter salvage in subcutaneous ports.

Methods: We retrospectively reviewed 300 subcutaneous single-lumen chest ports inserted by interventional radiologists in 294 patients between December 1, 1995, and November 15, 1997, at the Cleveland Clinic Foundation, Cleveland, Ohio. The number of days that the catheter remained in situ, infection rate, treatment, and outcome of infection were determined.

Results: Two hundred ninety-four patients had a total of 79 748 catheter-days. Vascular access for chemotherapy was the indication for 95% of the subcutaneous ports placed. Seventeen catheters (5.7%) developed 20 episodes of noninfectious complications resulting in the removal of 6 ports. Seventeen patients (5.7%) developed catheter-related infections (2.1/10 000 catheter-days) including 10 episodes of catheter-related bacteremia (1.2/10 000 catheter-days). The most common organism isolated was Staphylococcus aureus. A total of 15 of the 17 infected catheters were removed. Salvage was attempted in 6 patients in whom 4 catheters were eventually removed due to recurrent bacteremia (2 patients) and persistent local infection (2 patients). One of the 10 patients with catheter-related bacteremia developed septic arthritis. There were no complications associated with attempted catheter salvage.

Conclusions: Subcutaneous single-lumen ports inserted by interventional radiologists in patients undergoing chemotherapy have low complication rates but infections remain the leading cause of catheter loss. Antibiotic therapy without catheter removal is unlikely to eradicate catheter-related bacteremia.

Citing Articles

Infection of a venous port - beware of the Mycobacterium.

Heng T, Loh M, Chua Y, Tan B, Tan B J Radiol Case Rep. 2022; 16(9):1-10.

PMID: 36324604 PMC: 9584557. DOI: 10.3941/jrcr.v16i9.4587.


Current and Investigational Therapeutics for Fabry Disease.

Felis A, Whitlow M, Kraus A, Warnock D, Wallace E Kidney Int Rep. 2020; 5(4):407-413.

PMID: 32274449 PMC: 7136345. DOI: 10.1016/j.ekir.2019.11.013.


Diagnosis and management of catheter-related bloodstream infections in patients on home parenteral nutrition.

Bond A, Chadwick P, Smith T, Nightingale J, Lal S Frontline Gastroenterol. 2019; 11(1):48-54.

PMID: 31885840 PMC: 6914297. DOI: 10.1136/flgastro-2018-101094.


Value of superficial cultures for prediction of catheter-related bloodstream infection in long-term catheters: a prospective study.

Guembe M, Martin-Rabadan P, Echenagusia A, Camunez F, Rodriguez-Rosales G, Simo G J Clin Microbiol. 2013; 51(9):3025-30.

PMID: 23850957 PMC: 3754670. DOI: 10.1128/JCM.01351-13.


Implantable arterial port-related bloodstream infection in patients with primary or metastatic hepatic malignancies.

Honda H, Sakurai Y, Kang J, Nakamura T, Matsuura H, Warren D Am J Infect Control. 2013; 41(10):930-2.

PMID: 23594477 PMC: 4689132. DOI: 10.1016/j.ajic.2013.01.018.